PTCT
$43.18
Revenue | $186.7Mn |
Net Profits | $-99.18Mn |
Net Profit Margins | -53.12% |
Ptc Therapeutics, Inc.’s revenue fell -12.68% since last year same period to $186.7Mn in the Q2 2024. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated -11.14% fall in its revenue since last 3-months.
Ptc Therapeutics, Inc.’s net profit jumped 50.13% since last year same period to $-99.18Mn in the Q2 2024. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated -8.3% fall in its net profits since last 3-months.
Ptc Therapeutics, Inc.’s net profit margin jumped 42.89% since last year same period to -53.12% in the Q2 2024. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated -21.88% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -1.44 |
EPS Estimate Current Year | -1.44 |
Ptc Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.44 - a -37.14% fall from last quarter’s estimates.
Ptc Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -1.44.
Earning Per Share (EPS) | -1.27 |
Ptc Therapeutics, Inc.’s earning per share (EPS) jumped 52.26% since last year same period to -1.27 in the Q2 2024. This indicates that the Ptc Therapeutics, Inc. has generated 52.26% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-04-25 | -1.24 | -1.2 | 3.23% |
2024-08-08 | -1.05 | -1.27 | -20.95% |